Discover how Offred survives Gilead’s tyranny in The Handmaid’s Tale through silence, memory, and quiet rebellion, proving ...

The approval recommendation for lenacapavir is supported by solid Phase 3 data from the PURPOSE 1 and 2 studies. PURPOSE 1 ...

JPMorgan (NYSE: JPM) told investors in a note Monday that Eli Lilly & Co. (NYSE: LLY) shares are its “top pick” among U.S.

• Mount Gilead at Upper Sandusky, girls’ golf, 1:30 p.m. • Mount Gilead, Fredericktown and Harding at Cardington, boys’ golf, 4:30 p.m. • Northmor at Margaretta, girls’ golf, 5 p.m. • Highland at ...

Kymera Therapeutics' Q2 2025 earnings call highlights clinical progress, Gilead and Sanofi partnerships, and financial strength, setting a strong stage ...

A Menlo Park medical device startup is breathing new life into the fight against severe emphysema with a groundbreaking ...

Gift Nifty was trading 24,447 around level, a premium of nearly 6 points from the Nifty futures’ previous close, indicating a ...

Assembly Biosciences is advancing its herpes drug to Phase II trials after it showed 94% antiviral efficacy in a Phase Ib ...

Deutsche Bank analyst James Shin raised the firm’s price target on Gilead (GILD) to $135 from $120 and keeps a Buy rating on the shares. Published ...

Phase 1 healthy volunteer data surpassing Kymera’s target product profile, and further validating its oral, dupilumab-like profile KT-621 BroADen Phase 1b trial in moderate to severe atopic dermatitis ...